[關(guān)鍵詞]
[摘要]
心血管疾病是心臟和血管在內(nèi)的血液循環(huán)系統(tǒng)疾病,常見(jiàn)于中老年人群,其全球死亡率居首位。心血管病已經(jīng)成為了威脅人們生命健康的一大隱患,且死亡率正呈現(xiàn)逐年上升趨勢(shì)。大株紅景天注射液具有活血化瘀的功效,可改善心功能和血液微循環(huán)、抑制血栓形成、控制炎癥,對(duì)于心臟疾病的治療具有顯著療效,在治療部分血管疾病上有良好的輔助作用。對(duì)大株紅景天注射液治療冠心病、腦梗死等心血管疾病的臨床應(yīng)用進(jìn)行總結(jié),為大株紅景天注射液臨床合理應(yīng)用提供參考。
[Key word]
[Abstract]
Cardiovascular diseases are diseases of blood circulation system including heart and blood vessels, which are common in middle-aged and elderly people, and their global mortality rate ranks first. The mortality rate of cardiovascular diseases is increasing year by year, which has become a hidden danger to people's life and health. Sofren Injection has the effect of promoting blood circulation and removing blood stasis, and can improve heart function and blood microcirculation, inhibit thrombosis, control inflammation and other pharmacological effects. It has a significant effect on the treatment of heart diseases, and has a good auxiliary role in the treatment of some vascular diseases. This review summarizes the clinical application of Sofren Injection in treating coronary heart disease and cerebral infarction, and provides reference for the application of Sofren Injection in clinics.
[中圖分類號(hào)]
R972
[基金項(xiàng)目]
延邊大學(xué)應(yīng)用基礎(chǔ)項(xiàng)目[延大科合字(2021)第38號(hào);延大科合字(2019)第34號(hào)]